Proactive Investors - Run By Investors For Investors

Cellmid set to launch its anti-aging hair care range in major stores across the U.S.

Store presence is expected to increase sales, building on the successful online launch.
évolis® activator, shampoo and conditioner
évolis® activator, shampoo and conditioner

Cellmid Limited (ASX:CDY) will commence the instore launch of its anti-aging hair care range, évolis® Professional, on August 31, 2018 in Neiman Marcus and Soft Surroundings stores across the U.S.

As part of the launch, a series of experiential marketing events will be held in flagship Neiman Marcus stores in Hawaii (Ala Moana), California (Fashion Island), Florida (Orlando) and Texas (Northpark and Houston).

Similar events will be held in 11 Soft Surroundings stores, from Arizona to Texas, during the same period.

 

Neiman Marcus, founded in Dallas, Texas in 1907, is one of the oldest and most prestigious department stores in the U.S.

The group operates 42 Neiman Marcus stores across the United States and two Bergdorf Goodman stores in Manhattan.

Soft Surroundings, a women’s apparel, beauty and home décor chain, was founded as a catalogue business in St Louis, Missouri, and opened its first store in 2005.

Soft Surroundings has over 70 stores across the U.S. and is growing.

READ: Cellmid raises $9 million for distribution and invites shareholders to invest $1 million

The in-store launches are being supported by major public relations and social media campaigns in addition to full-day experiential marketing events hosted by each store.

The theme for each of the 16 events will be built around the use of Cellmid’s proprietary évoliscope™ technology, which allows customers to assess their hair health.

Cellmid chief executive officer Maria Halasz said: “Store presence is expected to increase sales significantly from what has been a very successful online launch of the évolis® Professional products in Neiman Marcus and Soft Surroundings.

“Previous events not only generated high conversion rates, but an opportunity to train store staff and allow them to become product champions.”

View full CDY profile View Profile

Cellmid Ltd Timeline

Related Articles

seeds in a bowl
March 08 2019
The Vancouver company is developing Omega-3 products as oil, powder or emulsion to be used as food additives
antibodies
May 02 2019
Avacta is using Affimers to develop its own cancer therapy, but it also licenses the technology to other companies, including major pharma group ModernaTX and LG Chem Life Sciences
1550850611_CancerHeadline.jpg
February 23 2019
Broker Hybridan reckons Sareum is “arguably a bargain target for the relatively large group of biotech and pharma companies interested in TYK2 and the wider JAK inhibitor space”

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use